Bioventus Inc.
BVSNasdaqCIK 1665988HealthcareFiscal year ends Dec 31
Reports and events: 114 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-05-1616:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-018425 |
| 2023-05-1608:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-145668 |
| 2023-05-1108:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-017427 |
| 2023-04-2708:30 ET | DEF 14A | Proxy statementPeriod 2023-06-07 | 0001193125-23-120232 |
| 2023-04-1117:17 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-097964 |
| 2023-04-0508:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-091610 |
| 2023-03-3116:08 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001628280-23-010151 |
| 2023-03-3107:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-010022 |
| 2023-03-0317:14 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001628280-23-006335 |
| 2023-02-2807:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure | 0001193125-23-052192 |
| 2023-01-0908:58 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-23-000737 |
| 2022-12-0716:15 ET | 8-K | 2.05 Exit or disposal costs | 0001628280-22-031531 |
| 2022-11-2117:15 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-030565 |
| 2022-11-2117:00 ET | 10-Q | Quarterly reportPeriod 2022-10-01 | 0001628280-22-030557 |
| 2022-11-1617:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-030171 |
| 2022-11-1509:06 ET | SC 13D/A | Ownership report, active investor, amended | 0001214659-22-013768 |
| 2022-11-0807:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-028761 |
| 2022-09-2716:03 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001628280-22-025553 |
| 2022-09-0118:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-22-024088 |
| 2022-08-1208:41 ET | 10-Q | Quarterly reportPeriod 2022-07-02 | 0001628280-22-022592 |
| 2022-08-1108:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-022333 |
| 2022-07-2116:01 ET | SC 13D | Ownership report, active investor | 0001214659-22-009064 |
| 2022-07-1216:53 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001628280-22-018848 |
| 2022-06-2917:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-185142 |
| 2022-06-2217:12 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-22-017806 |
| 2022-06-2116:59 ET | 8-K | 5.07 Shareholder vote results | 0001628280-22-017685 |
| 2022-05-1108:13 ET | 10-Q | Quarterly reportPeriod 2022-04-02 | 0001628280-22-013756 |
| 2022-05-1008:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-013461 |
| 2022-04-2916:06 ET | DEF 14A | Proxy statementPeriod 2022-06-17 | 0001193125-22-133580 |
| 2022-04-2609:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-22-010197 |
| 2022-04-0416:54 ET | 8-K | 8.01 Other events | 0001628280-22-008250 |
| 2022-03-1108:08 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001628280-22-005816 |
| 2022-03-1007:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-005648 |
| 2022-02-2816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-057853 |
| 2022-02-2516:53 ET | 8-K | 7.01 Regulation FD disclosure | 0001628280-22-004006 |
| 2022-01-1216:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-000815 |
| 2021-12-2709:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-21-025575 |
| 2021-11-2216:18 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-21-023966 |
| 2021-11-1716:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-332489 |
| 2021-11-1007:52 ET | 10-Q | Quarterly reportPeriod 2021-10-02 | 0001628280-21-022681 |
| 2021-11-0907:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-21-022399 |
| 2021-10-2917:06 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-313521 |
| 2021-10-2617:24 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-308139 |
| 2021-10-1817:02 ET | 8-K | 8.01 Other events | 0001193125-21-301150 |
| 2021-08-3016:22 ET | 8-K | 8.01 Other events | 0001628280-21-017784 |
| 2021-08-2516:42 ET | 8-K | 8.01 Other events | 0001628280-21-017617 |
| 2021-08-1107:49 ET | 10-Q | Quarterly reportPeriod 2021-07-03 | 0001628280-21-016502 |
| 2021-08-1016:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-21-016406 |
| 2021-07-2916:32 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-21-229264 |
| 2021-07-2916:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-21-014889 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 2, 2026, 17:44 ET. Listed shows no prices and gives no investment advice.